Correlation of Oxidized Low-Density Lipoprotein and C-Reactive Protein in Patients with Coronary Artery Disease

Cell Biochemistry and Biophysics

Volumn 65, Issue 2, 2013, Pages 285-286

  Huang, Yuli ^a   Wu, Yanxian ^a   Hu, Yunzhao ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874224453     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9409-3     Document Type: Letter

References (13)

1. Zhang, Y. C., Wei, J. J., Wang, F., Chen, M. T., & Zhang, M. Z. (2012). Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome. Cell Biochemistry and Biophysics, 62, 365-372.
2. Klingenberg, R., & Luscher, T. F. (2012). Inflammation in coronary artery disease and acute myocardial infarction-Is the stage set for novel therapies. Current Pharmaceutical Design [Epub ahead of print].
3. Fraley, A. E., & Tsimikas, S. (2006). Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Current Opinion in Lipidology, 17, 502-509.
4. Huang, Y., Hu, Y., Mai, W., et al. (2011). Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease. Disease Markers, 31, 295-301.
5. Ehara, S., Ueda, M., Naruko, T., et al. (2001). Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 103, 1955-1960.
6. Zouridakis, E., Avanzas, P., Arroyo-Espliguero, R., Fredericks, S., & Kaski, J. C. (2004). Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation, 110, 1747-1753.
7. Ishikawa, S., Kayaba, K., Gotoh, T., Nakamura, Y., & Kajii, E. (2007). Metabolic syndrome and C-reactive protein in the general population: JMS Cohort Study. Circulation Journal: Official Journal of the Japanese Circulation Society, 71, 26-31.
8. Ueba, T., Nomura, S., Nishikawa, T., Kajiwara, M., & Yamashita, K. (2009). Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese. Atherosclerosis, 203, 243-248.
9. Wu, T., Willett, W. C., Rifai, N., Shai, I., Manson, J. E., & Rimm, E. B. (2006). Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U. S. men and women. Journal of the American College of Cardiology, 48, 973-979.
10. Tsimikas, S., Brilakis, E. S., Miller, E. R., et al. (2005). Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. The New England Journal of Medicine, 353, 46-57.
11. Yan, J. C., Zhu, J., Gao, L., et al. (2004). The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes. Clinica Chimica Acta; International Journal of Clinical Chemistry, 343, 155-159.
12. Holvoet, P., Vanhaecke, J., Janssens, S., van de Werf, F., & Collen, D. (1998). Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation, 98, 1487-1494.
13. Meisinger, C., Baumert, J., Khuseyinova, N., Loewel, H., & Koenig, W. (2005). Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation, 112, 651-657.